Trinbelimab

N/A

Report date: 2024/04/19 15:02:43

Base Information

Drug NameTrinbelimab
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionBlood group Rh(D) polypeptide inhibitors
TargetsBlood group Rh(D) polypeptide
Therapy Area/IndicationsErythroblastosis, Fetal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLokmanya Tilak Municipal General Hospital, Mumbai
China Registration ClassN/A

Develop Information

Active CompaniesLokmanya Tilak Municipal General Hospital, Mumbai
Inactive CompaniesN/A
Active IndicationsErythroblastosis, Fetal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A